BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17590846)

  • 1. Current management of renal cell carcinoma and targeted therapy.
    Canda AE; Kirkali Z
    Urol J; 2006; 3(1):1-14. PubMed ID: 17590846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic and partial nephrectomy.
    Novick AC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6322S-7S. PubMed ID: 15448025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of advanced and metastatic renal cell carcinoma.
    Ather MH; Masood N; Siddiqui T
    Urol J; 2010; 7(1):1-9. PubMed ID: 20209445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of nephron-sparing surgery.
    Van Poppel H
    Int J Urol; 2010 Apr; 17(4):314-26. PubMed ID: 20409229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing concepts in the surgical management of renal cell carcinoma.
    Lam JS; Shvarts O; Pantuck AJ
    Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the indications for laparoscopic radical nephrectomy.
    Mattar K; Finelli A
    Curr Opin Urol; 2007 Mar; 17(2):88-92. PubMed ID: 17285016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned in the surgical management of renal cell carcinoma.
    Sengupta S; Zincke H
    Urology; 2005 Nov; 66(5 Suppl):36-42. PubMed ID: 16194705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
    Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
    Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of renal cell carcinoma with vena cava tumor thrombi].
    Li XF; Zhou FJ; Qiu SP; Liu ZW; Wu RP; Huang K; Mei H
    Ai Zheng; 2004 Sep; 23(9):1074-6. PubMed ID: 15363205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.